A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 1, 2008, Pages 23-30

  Egle, Roman ^a,b   Milek, Miha ^b   Mlinarič Raščan, Irena ^b   Fahr, Alfred ^a   Kristl, Julijana ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Artificial viral particle; Gene delivery; Nanoparticles; Non viral vector; Plasmid DNA; Thiopurine S methyltransferase; TPMT; Transfection

Indexed keywords

ANION; CATION; CHOLESTEROL; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOSOME; MERCAPTOPURINE; POLYETHYLENEIMINE; PURINE DERIVATIVE; RECOMBINANT PROTEIN; THIOPURINE METHYLTRANSFERASE; THREO 3,4 DIHYDROXYPHENYLSERINE;

ARTICLE; CELL LINE; CELL POPULATION; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL TYPE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME METABOLISM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LEUKEMIA CELL LINE; MOLECULAR CLONING; MOLECULAR WEIGHT; PROTEIN EXPRESSION; VIRUS PARTICLE;

CELL LINE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; JURKAT CELLS; METHYLTRANSFERASES; PLASMIDS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 41549138197     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.10.004     Document Type: Article

References (33)

1. Fischer A. Gene therapy: some results, many problems to solve. Cell. Mol. Biol. 47 (2001) 1269-1275
2. Breunig M., Lungwitz U., Liebl R., Fontanari C., Klar J., Kurtz A., Blunk T., and Goepferich A. Gene delivery with low molecular weight linear polyethylenimines. J. Gene Med. 7 (2005) 1287-1298
3. Zaric V., Weltin D., Erbacher P., Remy J.S., Behr J.P., and Stephan D. Effective polyethylenimine-mediated gene transfer into human endothelial cells. J. Gene Med. 6 (2004) 176-184
4. Filion M.C., and Phillips N.C. Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162 (1998) 159-170
5. Belguise-Valladier P., and Behr J.P. Nonviral gene delivery: towards artificial viruses. Cytotechnology 35 (2001) 197-201
6. Wagner E. Strategies to improve DNA polyplexes for in vivo gene transfer: will {minus 45 degree rule}"artificial viruses{minus 45 degree rule}" be the answer?. Pharm. Res. 21 (2004) 8-14
7. Zuber G., Dauty E., Nothisen M., Belguise P., and Behr J.P. Towards synthetic viruses. Adv. Drug Deliv. Rev. 52 (2001) 245-253
8. Nahde T., Muller K., Fahr A., Muller R., and Brusselbach S. Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles. J. Gene Med. 3 (2001) 353-361
9. Muller K., Nahde T., Fahr A., Muller R., and Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther. 8 (2001) 107-117
10. Toenges L., Lingor P., Egle R., Dietz G.P.H., Fahr A., and Baehr M. Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA 12 (2006) 1431-1438
11. Woodson L.C., and Weinshilboum R.M. Human kidney thiopurine methyltransferase. Purification and biochemical properties. Biochem. Pharmacol. 32 (1983) 819-826
12. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur. J. Clin. Pharmacol. 43 (1992) 329-339
13. Schaeffeler E., Fischer C., Brockmeier D., Wernet D., Moerike K., Eichelbaum M., Zanger U.M., and Schwab M. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14 (2004) 407-417
14. Wu H., Horton J.R., Battaile K., Allali-Hassani A., Martin F., Zeng H., Loppnau P., Vedadi M., Bochkarev A., Plotnikov A.N., and Cheng X. Structural basis of allele variation of human thiopurine-S-methyltransferase. Proteins 67 (2007) 198-208
15. Tai H.L., Fessing M.Y., Bonten E.J., Yanishevsky Y., d'Azzo A., Krynetski E.Y., and Evans W.E. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. Pharmacogenetics 9 (1999) 641-650
16. Milek M., Murn J., Jaksic Z., Lukac Bajalo J., Jazbec J., and Mlinaric Rascan I. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population. Pharmacology 77 (2006) 105-114
17. Weinshilboum R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab. Dispos. 29 (2001) 601-605
18. Krynetski E.Y., Tai H.L., Yates C.R., Fessing M.Y., Loennechen T., Schuetz J.D., Relling M.V., and Evans W.E. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 6 (1996) 279-290
19. Lennard L., Lilleyman J.S., Van Loon J., and Weinshilboum R.M. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336 (1990) 225-229
20. Evans W.E., Horner M., Chu Y.Q., Kalwinsky D., and Roberts W.M. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J. Pediatr. 119 (1991) 985-989
21. Loennechen T., Utsi E., Hartz I., Lysaa R., Kildalsen H., and Aarbakke J. Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in Northern Norway. Clin. Pharmacol. Ther. 70 (2001) 183-188
22. Dervieux T., Blanco J.G., Krynetski E.Y., Vanin E.F., Roussel M.F., and Relling M.V. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res. 61 (2001) 5810-5816
23. Coulthard S.A., Hogarth L.A., Little M., Matheson E.C., Redfern C.P.F., Minto L., and Hall A.G. The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs. Mol. Pharmacol. 62 (2002) 102-109
24. Honchel R., Aksoy I.A., Szumlanski C., Wood T.C., Otterness D.M., Wieben E.D., and Weinshilboum R.M. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol. Pharmacol. 43 (1993) 878-887
25. Murn J., Urleb U., and Mlinaric-Rascan I. Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease. Genes Cells 9 (2004) 1103-1111
26. Szumlanski C.L., Honchel R., Scott M.C., and Weinshilboum R.M. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 2 (1992) 148-159
27. Lee D., Szumlanski C., Houtman J., Honchel R., Rojas K., Overhauser J., Wieben E.D., and Weinshilboum R.M. Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1. Drug Metab. Dispos. 23 (1995) 398-405
28. Ford L., Graham V., and Berg J. Whole-blood thiopurine S-methyltransferase activity with genotype concordance: a new, simplified phenotyping assay. Ann. Clin. Biochem. 43 (2006) 354-360
29. Schakowski F., Buttgereit P., Mazur M., Maerten A., Schoettker B., Gorschlueter M., and Schmidt-Wolf I.G.H. Novel non-viral method for transfection of primary leukemia cells and cell lines. Gen. Vac. Ther. 2 (2004)
30. Van Loon J.A., and Weinshilboum R.M. Thiopurine methyltransferase biochemical genetics: human lymphocyte activity. Biochem. Gen. 20 (1982) 637-658
31. Vora A., Mitchell C.D., Lennard L., Eden T., Kinsey S.E., Lilleyman J., and Richards S.M. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 368 (2006) 1339-1348
32. Bendas G., Krause A., Schmidt R., Vogel J., and Ulrich R. Selectins as new targets for immunoliposome-mediated drug delivery: a potential way of anti-inflammatory therapy. Pharm. Acta Helv. 73 (1998) 19-26
33. Peter Hölig, Erzeugung und Charakterisierung zielgerichteter liposomaler Trägersysteme für die Tumortherapie, Doctoral Thesis, Phillips Universität Marburg, (2007).